Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic...

This chapter provides an introduction and outlines the rationale for this book. It also specifies the organisation and structure of the chapter contributions while introducing the authors. The chapter concludes by summarising the main points of the ensuing sections and intimates on directions...